These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 874071)

  • 1. Pathogenicity of nonpigmented cultures of Chromobacterium violaceum.
    Sivendra R; Tan SH
    J Clin Microbiol; 1977 May; 5(5):514-6. PubMed ID: 874071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of Chromobacterium violaceum: pigmented and non-pigmented strains.
    Sivendra R; Lo HS
    J Gen Microbiol; 1975 Sep; 90(1):21-31. PubMed ID: 1236933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonpigmented strain of
    Tiwari S; Pattanaik S; Beriha SS
    Indian J Pathol Microbiol; 2017; 60(3):427-429. PubMed ID: 28937390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unusual Chromobacterium violaceum: aerogenic strains.
    Sivendra R
    J Clin Microbiol; 1976 Jan; 3(1):70-1. PubMed ID: 1254704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromobacterium subtsugae sp. nov., a betaproteobacterium toxic to Colorado potato beetle and other insect pests.
    Martin PAW; Gundersen-Rindal D; Blackburn M; Buyer J
    Int J Syst Evol Microbiol; 2007 May; 57(Pt 5):993-999. PubMed ID: 17473247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromobacterium pathogenicity island 1 type III secretion system is a major virulence determinant for Chromobacterium violaceum-induced cell death in hepatocytes.
    Miki T; Iguchi M; Akiba K; Hosono M; Sobue T; Danbara H; Okada N
    Mol Microbiol; 2010 Aug; 77(4):855-72. PubMed ID: 20545857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Virulence determinant of Chromobacterium violaceum].
    Miki T
    Nihon Saikingaku Zasshi; 2014; 69(4):577-88. PubMed ID: 25447983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferric Uptake Regulator Fur Coordinates Siderophore Production and Defense against Iron Toxicity and Oxidative Stress and Contributes to Virulence in Chromobacterium violaceum.
    Santos RERS; Batista BB; da Silva Neto JF
    Appl Environ Microbiol; 2020 Oct; 86(21):. PubMed ID: 32859594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Chromobacterium violaceum type III effector CopE, a guanine nucleotide exchange factor for Rac1 and Cdc42, is involved in bacterial invasion of epithelial cells and pathogenesis.
    Miki T; Akiba K; Iguchi M; Danbara H; Okada N
    Mol Microbiol; 2011 Jun; 80(5):1186-203. PubMed ID: 21435035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production and Uptake of Distinct Endogenous Catecholate-Type Siderophores Are Required for Iron Acquisition and Virulence in Chromobacterium violaceum.
    Batista BB; Santos RERS; Ricci-Azevedo R; da Silva Neto JF
    Infect Immun; 2019 Dec; 87(12):. PubMed ID: 31570563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chromobacterium violaceum, opportunist pathogenic bacteria in tropical and subtropical regions].
    Richard C
    Bull Soc Pathol Exot; 1993; 86(3):169-73. PubMed ID: 8219788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two cases of Chromobacterium violaceum infection after injury in a subtropical region.
    Lee J; Kim JS; Nahm CH; Choi JW; Kim J; Pai SH; Moon KH; Lee K; Chong Y
    J Clin Microbiol; 1999 Jun; 37(6):2068-70. PubMed ID: 10325383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phagocyte NADPH oxidase, but not inducible nitric oxide synthase, is essential for early control of Burkholderia cepacia and chromobacterium violaceum infection in mice.
    Segal BH; Ding L; Holland SM
    Infect Immun; 2003 Jan; 71(1):205-10. PubMed ID: 12496167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromobacterium violaceum and its important metabolites--review.
    Durán M; Faljoni-Alario A; Durán N
    Folia Microbiol (Praha); 2010 Nov; 55(6):535-47. PubMed ID: 21253897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative biogeography of Chromobacterium from the neotropics.
    Lima-Bittencourt CI; Costa PS; Hollatz C; Raposeiras R; Santos FR; Chartone-Souza E; Nascimento AM
    Antonie Van Leeuwenhoek; 2011 Feb; 99(2):355-70. PubMed ID: 20803105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromobacterium violaceum: important insights for virulence and biotechnological potential by exoproteomic studies.
    Ciprandi A; da Silva WM; Santos AV; de Castro Pimenta AM; Carepo MS; Schneider MP; Azevedo V; Silva A
    Curr Microbiol; 2013 Jul; 67(1):100-6. PubMed ID: 23455494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chromobacterium violaceum: a review of pharmacological and industiral perspectives.
    Durán N; Menck CF
    Crit Rev Microbiol; 2001; 27(3):201-22. PubMed ID: 11596879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aerocavin, a new antibiotic produced by Chromobacterium violaceum.
    Singh PD; Liu WC; Gougoutas JZ; Malley MF; Porubcan MA; Trejo WH; Wells JS; Sykes RB
    J Antibiot (Tokyo); 1988 Apr; 41(4):446-53. PubMed ID: 3372350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sepsis caused by Chromobacterium violaceum - probably the first case in Europe, or
    Jędruszczak A; Węgrzyn-Bąk M; Budzyńska-Nosal R; Maciejewski M; Marczewski K
    Ann Agric Environ Med; 2019 Sep; 26(3):508-510. PubMed ID: 31559812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Zinc Transporter ZnuABC Is Critical for the Virulence of Chromobacterium violaceum and Contributes to Diverse Zinc-Dependent Physiological Processes.
    Santos RERS; da Silva Júnior WP; Harrison S; Skaar EP; Chazin WJ; da Silva Neto JF
    Infect Immun; 2021 Oct; 89(11):e0031121. PubMed ID: 34370507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.